SNTISenti Biosciences Holdings, Inc.
- Market cap
- $5.87M
- as of 2026-10-23
- Latest close
- $0.19
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-02-02
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Oct 21 | Oct 23 | F | 19,953 | $0.00 | $0 | 54,890 | No | Form 4 |
| Lu Timothy KCEO | Oct 21 | Oct 23 | F | 157,312 | $0.00 | $0 | 482,271 | No | Form 4 |
| Lu Timothy KCEO | Mar 9 | Mar 11 | F | 80,666 | $0.00 | $0 | 639,583 | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Mar 9 | Mar 11 | F | 10,757 | $0.00 | $0 | 74,843 | No | Form 4 |
| Lu Timothy KCEO | Feb 2 | Feb 3 | F | 4,191 | $0.00 | $0 | 720,249 | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Feb 2 | Feb 3 | F | 1,384 | $0.00 | $0 | 85,600 | No | Form 4 |
| Baum Bryan Daniel | Jul 18, 2025 | Jul 21, 2025 | A · derivative | 43,900 | $1.95 | $85,605 | 43,900 | No | Form 4 |
| Mathers Edward T | Jun 25, 2025 | Jun 27, 2025 | A · derivative | 21,950 | $2.05 | $44,998 | 21,950 | No | Form 4 |
| Tang Donald F | Jun 25, 2025 | Jun 27, 2025 | A · derivative | 21,950 | $2.05 | $44,998 | 21,950 | No | Form 4 |
| Cooperstone Brenda | Jun 25, 2025 | Jun 27, 2025 | A · derivative | 21,950 | $2.05 | $44,998 | 21,950 | No | Form 4 |
| Schulz Fran | Jun 25, 2025 | Jun 27, 2025 | A · derivative | 21,950 | $2.05 | $44,998 | 21,950 | No | Form 4 |
| Hsiung Feng | Jun 25, 2025 | Jun 27, 2025 | A · derivative | 21,950 | $2.05 | $44,998 | 21,950 | No | Form 4 |
| Collins James J. | Jun 25, 2025 | Jun 27, 2025 | A · derivative | 21,950 | $2.05 | $44,998 | 21,950 | No | Form 4 |
| Celadon Partners SPV 24 | Mar 10, 2025 | Mar 14, 2025 | C | 9,777,000 | not reported | not reported | 9,777,000 | No | Form 4 |
| Celadon Partners SPV 24 | Mar 10, 2025 | Mar 14, 2025 | C · derivative | 9,777 | not reported | not reported | not reported | No | Form 4 |
| Florence Anthony A. Jr. | Mar 10, 2025 | Mar 12, 2025 | C | 3,333,000 | not reported | not reported | 3,775,615 | No | Form 4 |
| Florence Anthony A. Jr. | Mar 10, 2025 | Mar 12, 2025 | C · derivative | 3,333 | not reported | not reported | not reported | No | Form 4 |
| Bayer US Holding LP | Mar 10, 2025 | Mar 12, 2025 | C | 2,222,000 | not reported | not reported | 2,809,848 | No | Form 4 |
| Bayer US Holding LP | Mar 10, 2025 | Mar 12, 2025 | C · derivative | 2,222 | not reported | not reported | not reported | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Mar 10, 2025 | Mar 11, 2025 | C | 33,000 | $2.25 | $74,250 | 33,000 | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Mar 10, 2025 | Mar 11, 2025 | C · derivative | 33 | $2,250.00 | $74,250 | not reported | No | Form 4 |
| Mathers Edward T | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 43,900 | $3.52 | $154,528 | 43,900 | No | Form 4 |
| Cross John Harry IIIChief Financial Officer | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 174,200 | $3.52 | $613,184 | 174,200 | No | Form 4 |
| Hsiung Feng | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 43,900 | $3.52 | $154,528 | 43,900 | No | Form 4 |
| Cooperstone Brenda | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 43,900 | $3.52 | $154,528 | 43,900 | No | Form 4 |
| Tang Donald F | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 43,900 | $3.52 | $154,528 | 43,900 | No | Form 4 |
| Collins James J. | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 43,900 | $3.52 | $154,528 | 43,900 | No | Form 4 |
| Schulz Fran | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 43,900 | $3.52 | $154,528 | 43,900 | No | Form 4 |
| Lu Timothy KCEO and Interim PFO and PAO | Mar 7, 2025 | Mar 10, 2025 | A | 642,358 | $0.00 | $0 | 724,440 | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Mar 7, 2025 | Mar 10, 2025 | A | 78,363 | $0.00 | $0 | 86,984 | No | Form 4 |
| Lu Timothy KCEO and Interim PFO and PAO | Mar 6, 2025 | Mar 10, 2025 | A · derivative | 1,927,073 | $3.97 | $7,650,480 | 1,927,073 | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Mar 6, 2025 | Mar 10, 2025 | A · derivative | 235,088 | $3.97 | $933,299 | 235,088 | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Feb 6, 2025 | Feb 6, 2025 | S | 182 | $4.37 | Sale −$795 | 8,621 | No | Form 4 |
| Lu Timothy KCEO | Feb 6, 2025 | Feb 6, 2025 | S | 545 | $4.36 | Sale −$2,376 | 82,082 | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Feb 4, 2025 | Feb 6, 2025 | S | 1,297 | $4.07 | Sale −$5,279 | 8,803 | No | Form 4 |
| Lu Timothy KCEO | Feb 4, 2025 | Feb 6, 2025 | S | 3,922 | $4.07 | Sale −$15,963 | 82,627 | No | Form 4 |
| Bayer US Holding LP | Dec 9, 2024 | Dec 11, 2024 | P · derivative | 2,222 | not reported | Purchase not reported | 2,222 | No | Form 4 |
| Bayer US Holding LP | Dec 9, 2024 | Dec 11, 2024 | P · derivative | 3,333,000 | $2.30 | Purchase +$7,665,900 | 3,330,000 | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Dec 9, 2024 | Dec 10, 2024 | A · derivative | 33 | $2,250.00 | $74,250 | 33 | No | Form 4 |
| Rajangam KanyaPres. & Chief Med. & Dev. Off. | Dec 9, 2024 | Dec 10, 2024 | A · derivative | 49,500 | $2.30 | $113,850 | 49,500 | No | Form 4 |
| Schulz Fran | Dec 9, 2024 | Dec 10, 2024 | A · derivative | 12,500 | $6.52 | $81,500 | 12,500 | No | Form 4 |
| Tang Donald F | Dec 9, 2024 | Dec 10, 2024 | A · derivative | 12,500 | $6.52 | $81,500 | 12,500 | No | Form 4 |
| Mathers Edward T | Jul 10, 2024 | Jul 12, 2024 | A · derivative | 62,500 | $0.31 | $19,375 | 62,500 | No | Form 4 |
| Cooperstone Brenda | Jul 10, 2024 | Jul 12, 2024 | A · derivative | 62,500 | $0.31 | $19,375 | 62,500 | No | Form 4 |
| Collins James J. | Jul 10, 2024 | Jul 12, 2024 | A · derivative | 62,500 | $0.31 | $19,375 | 62,500 | No | Form 4 |
| Farokhzad Omid | Jul 10, 2024 | Jul 12, 2024 | A · derivative | 62,500 | $0.31 | $19,375 | 62,500 | No | Form 4 |
| Knobelman DeborahChief Financial Officer | Feb 1, 2024 | Feb 2, 2024 | A | 101,000 | $0.00 | $0 | 131,000 | No | Form 4 |
| Knobelman DeborahChief Financial Officer | Feb 1, 2024 | Feb 2, 2024 | A · derivative | 152,000 | $0.46 | $69,920 | 152,000 | No | Form 4 |
| Lu Timothy KCEO and President | Feb 1, 2024 | Feb 2, 2024 | A | 306,000 | $0.00 | $0 | 865,496 | No | Form 4 |
| Lu Timothy KCEO and President | Feb 1, 2024 | Feb 2, 2024 | A · derivative | 459,000 | $0.46 | $211,140 | 459,000 | No | Form 4 |
| Rajangam KanyaChief Medical & Devt. Officer | Feb 1, 2024 | Feb 2, 2024 | A | 101,000 | $0.00 | $0 | 101,000 | No | Form 4 |
| Rajangam KanyaChief Medical & Devt. Officer | Feb 1, 2024 | Feb 2, 2024 | A · derivative | 152,000 | $0.46 | $69,920 | 152,000 | No | Form 4 |